Huge amounts of data are continuously being generated in the healthcare system. A correct and careful analysis of these data may bring huge benefits to all people and processes involved in the healthcare management. However, the characteristics of healthcare data do not make this job easy. These data are usually too complex, massive, with high dimensionality, and are irregularly distributed over time. In the last decade, data mining has begun to address this area, providing the technology and approaches to transform these complex data into useful information for decision support. Multi-relational data mining, in particular, has gained attention since it aims for the discovery of frequent relations that involve multiple dimensions. In this work we present a case study on the healthcare domain. Using the Hepatitis dataset, we show how that data can be modeled and explored in a multi-dimensional model, and we present and discuss the results of applying a multi-dimensional data mining algorithm to that model.
INTRODUCTION
Huge amounts of data are continuously being generated in the healthcare system. The analysis of these data is mandatory, since it may help in many areas of healthcare management, such as evaluating treatment effectiveness, understanding causes and effects, anticipating future demanded resources, predicting patient's behaviors and best treatments, defining best practices, etc. (Koh and Tan, 2005; Kaur and Wasan, 2006) . Due to the nature of this information, results of these analysis may make the difference, by decreasing healthcare costs and, at the same time, improving the quality of healthcare services and patients' life.
Healthcare data are usually massive, too sparse and complex to be analyzed by hand with traditional methods. In the last decade, data mining has begun to address this area, providing the technology and approaches to transform huge and complex data into useful information for decision making (Koh and Tan, 2005) . Data mining (DM) is defined as the "non trivial extraction of implicit, previously unknown, and potentially useful information about data" (Frawley et al., 1992) . It has been successively applied to many different subfields of healthcare management, which results proved to be very useful to all parts involved (Koh and Tan, 2005; Kaur and Wasan, 2006) .
One of the characteristics of the data collected in the healthcare domain is their high dimensionality. They include patient personal attributes, resource management data, medical test results, conducted treatments, hospital and financial data, etc. Thus, healthcare organizations must capture, store and analyze these multi-dimensional data efficiently.
Multi-Relational Data Mining, or MRDM (Džeroski, 2003) is an area that aims for the discovery of frequent relations that involve multiple tables, in their original structure, i.e. without joining all the tables before mining. In recent years, the most common mining techniques have been extended to the multi-relational context. However, there are few capable of dealing with a massive number of records, and of taking into consideration all dimensions at the same time (Silva and Antunes, 2012) .
In this work we present a case study on the healthcare domain, showing how existing data can be explored. The case is based on the use of the Hepatitis dataset, created by Chiba University Hospital, containing information about 771 patients having hepatitis B or C, and more than 2 million examinations dating from 1982 to 2001. This dataset is organized in a relational model that may help data storage, but hinders data analysis, since the same type of information is scattered through different tables, and it is not easy to inter-relate the data in a timeline. In this work we propose a multi-dimensional model for the Hepatitis dataset, that makes it possible an efficient analysis and knowledge extraction. We also present some statistics, in order to better understand the the distributions of the data in this domain. After modeling the dataset through a multidimensional model, we analyze the application of data mining to these models, and present the results of applying a traditional MRDM algorithm -the StarFPStream (Silva and Antunes, 2012) , to the proposed model. Results show that using this model it is possible to mine these data efficiently to address several goals, and that it is possible to find interesting relations. However, due to the nature and distributions of these data, there is the need for further analysis, with e.g. the application of different types of algorithms.
Section 2 describes the Hepatitis dataset and section 3 proposes a multi-dimensional model for the Hepatitis data, in order to promote their analysis for decision making. Section 4 describes how can we apply data mining to a multi-dimensional model, and section 5 shows and discusses our goals, approaches and results. Finally, section 6 concludes the work.
THE HEPATITIS CASE STUDY
The Hepatitis dataset 1 contains information about laboratory examinations and treatments taken on the patients of hepatitis B and C, who were admitted to Chiba University Hospital in Japan. There are 771 patients, and more than 2 million examinations dating from 1982 to 2001, from about 900 different blood and urine types of exams. The dataset also contains data about the biopsies (about 695 biopsy results) and interferon treatments (about 200) performed to patients. Biopsies reveal the true existence of hepatitis and respective fibrosis state. However, they are invasive procedures, and therefore there is an interest in finding other indicators that allow the detection of hepatitis in a more friendly way. Interferon treatments have also been seen and used as an effective way to treat hepatitis C, although it has tough side effects, and its efficacy is not yet proved. Hence there is the need to understand the impact of this treatment.
The hepatitis dataset is composed of several data tables, modeled in a relational schema centered on the patient. This model is shown in figure 1 . Each patient may have performed some biopsies, several hematological analysis, in-hospital and out-hospital exams, and may also be under interferon therapy. Each one Figure 1 depicts the main tables involved in the hepatitis database. The patients' various exams are not directly related, so joining these tables for a common analysis fails to provide a suitable dataset for discovering association rules based on traditional data mining algorithms such as Apriori [4] , . In other words, the results deriving from joint tables may lead to data redundancy and thence to distortions in the calculation of the support and confidence measures of interest.
Patient Interferon Therapy
Hematological Analysis
In-Hospital Examination

Results of Biopsy
Out-Hospital Examination
Fig. 1 -Hepatitis dataset tables
To better explain this problem, consider the three tables in Figure 2 , which contain data on urinalysis and biopsy results, join them in a third table based on the attributes {MID, Month, Year}. Consider, also, that our aim is to define whether these two types of exams are related.
In Figure 2 , note that the tuple (MID=772, Month=2, Year=1999, Fibrosis=F4) appears in 20% of the Biopsy Therefore, to analyze the datasets correctly and obtain rules for the biopsy results and the other types of exams, we applied the Connection algorithm to the hepatitis database.
The Connection Algorithm
The Connection algorithm mines Boolean association rules from several tables that have at least one attribute in common, without joining the tables. This algorithm was originally proposed to mine data from data warehouses [1, 2] , but the proposed method can be used to mine multiple tables of a relational database. (Pizzi et al., 2005) . of these aspects is stored in one different table and is independent of the others.
Despite being modular, this schema does not facilitates the analysis of these data, for several reasons: (1) the various exams -both in-, out-hospital and hematological analysis -are not directly related, although the same type of exams may be present in more than one table; (2) relating both exams, or exams and biopsies or interferon therapy requires joining the tables for a common analysis. This process of joining the tables is time consuming and non trivial, and the resulting table hinders the analysis, since it will contain lots of redundant data, as well as lots of missing values; and (3) time is not directly modeled, and therefore there is no easy way to understand the interconnection between co-occurring events (e.g. exam results during interferon therapy), neither the disease evolution. Moreover, most data are distributed irregularly, either in time, as well as per patient, making a direct analysis unfeasible.
The work presented in (Pizzi et al., 2005 ) is the first step on the multi-dimensional analysis of the hepatitis data. The authors use a multi-relational algorithm to connect biopsies and urinal exams, and to generate association rules that estimate the stage of liver fibrosis based on lab tests. However, they are only able to mine two dimensions of the relational model at a time, and therefore they cannot relate the biopsies with, for example, both the blood tests (Hematological Analysis) and the other tests (In-and Out-Hospital Examinations).
THE MULTI-DIMENSIONAL MODEL
As stated before, one of the characteristics of the data collected in the healthcare domain is their high dimensionality. In the case of the Hepatitis dataset, we have administrative data such as patient's features (sex and date of birth), pathological classification of the disease (given by biopsy results), duration of interferon therapy, and temporal data about the blood and urine tests performed to patients. Note that we could have more data, such as treatment and tests' cost, hospital data related to out-hospital exams, informa- tion about doctors in charge of patients, etc., which would increase the dimensionality of the dataset and the complexity of the relational model. One efficient way to store high-dimensional data is through the use of a multi-dimensional model -a star schema, in particular. A star schema clearly divides the different dimensions of a domain into a set of separated data tables, interrelated by a central table, representing the occurring events. In the case of the Hepatitis data, we can identify several dimensionspatient, biopsy, possible exams and date information -and events correspond to patient examinations.
In this sense, one of the possible star schemas that can be defined is proposed in figure 2. The star schema is composed of 4 dimensions (Patient, Biopsy, Exam Type and Date) and one central fact table that corresponds to the Examination Results. Each dimension is independent and contains the respective characteristics (Patient contains patients' features, and Exam Type contains data about possible exams, like upper and lower bounds and units). By analyzing the central table, we can understand the relation between all dimensions: one patient P, with active biopsy B, performed exam E on date D. The result of this event was r (given by attribute Result in the central table), and at the moment of this examination, it was (or not) being administrated interferon therapy (attribute InInter f eronT herapy?).
Adding new dimensions to this star schema is straightforward. For example, we could add dimensions Hospital and Doctor just by adding the respective keys into the central table, and each event in that table would correspond to one exam E, performed to patient P, with active biopsy B, on date D, in hospital H with doctor Doc.
Building the Star Schema
In order to build our star schema, we had to perform a pre-processing phase to join exam data from the different tables and improve their quality.
First, we decided to reduce data and select only the most significant exams, based on the report carried out by (Watanabe et al., 2003) . These exams are GOT, GPT, ZTT, TTT, T-BIL, D-BIL, I-BIL, ALB, CHE, T-CHO, TP, WBC, RBC, HGB, HCT, MCV and PLT. In this sense, dimension Exam Type contains the known data about these exams (i.e. code, bounds and units). The reason for this data reduction is that other exams are so rare that one cannot draw any conclusion based on them. Another reason is the fact that, due to the lack of domain knowledge, we can only interpret the results of these exams (as normal or abnormal results). Dimension Patient is equivalent to the original table in the Hepatitis dataset, and Biopsy contains only the possible outputs of biopsies (type can be B or C, the fibrosis state varies from 0 to 4, and respective activity from 0 to 3). Note that dimension Date contains all dates from 1982 to 2001 and is trivial to generate.
Since these exams are spread in both Hematological Analysis, In-and Out-Hospital Examination tables, each row of these tables corresponds to one event (one examination) in the central table of the star schema. Then, exam results were categorized into 7 degrees: extremely, very or simply high (UH, VH, H), normal (N), low, very or extremely low (L, VL, UL). The thresholds and categories for each of the selected exams are described in (Watanabe et al., 2003) , and are not presented here due to space restrictions. The exam results of patients with more than one result for the same type of exam in one day were averaged.
Fibrosis are considered stable 500 days before and 500 days after a biopsy (Watanabe et al., 2003) . Therefore, for each examination in the central table, the corresponding active biopsy is the most recent one performed for the patient, within the 500 days interval (or none).
Finally, interferon therapy data was also integrated in the multi-dimensional star, by marking all examinations in the central table made during the administration of this therapy (using the information on the Interferon Therapy table of the relational model).
Understanding the data
After building the star schema for the Hepatitis dataset as described above, it resulted in a central table with almost 600 thousand examinations performed, for 722 patients (the other 50 patients have not performed none of the most significant exams, therefore they remain on the Patient dimension, but are not present in the central table).
In order to better understand the domain in ques- tion, figure 3 shows the distribution of the exams per patient. We can see that, on one side, there are patients with just a few exams, and on another side, patients with more than 2500 exams. However, in average, each patient performed about 500 -700 exams. Also, only 30% of all patients are feminine, but women perform, in average, more exams than men. From these patients, 234 have not performed any biopsy, which means that they were not diagnosed with any type of hepatitis, yet. The number of examinations performed to patients with hepatitis B, C or none is shown in figure 4 . Note that, from all patients, only 27.5% were diagnosed with hepatitis B, at some point in time, 40% with hepatitis C, and the rest 32.5% have no biopsy. We can see in that figure that patients with hepatitis C perform much more exams than patients with hepatitis B. One possible explanation is the fact that hepatitis C has been treated with interferon therapy, and therefore more exams (and biopsies) are performed to check if results improve.
Also, patients with no biopsy made much less exams than the others. This may indicate that they Hepa%%s'C' did not undertake the biopsy, because doctors thought these patients were not infected with hepatitis B or C, and therefore the biopsy was not necessary. Figure 5 presents the variation of the number of exams per state of hepatitis (fibrosis). A value of 0 means that there is no fibrosis, and 4 that the state of the fibrosis is severe. Note that only one fifth of the total examinations (about 137 hundred) are performed while there is a valid biopsy (they are active 500 days before and after they are conducted).
As expected, there are more cases of hepatitis in their early states than in severe states. In the case of hepatitis C, 50% of all performed exams correspond to patients in state 1 of fibrosis. This means that, in order to find correlations between exams and fibrosis states, we are analyzing patterns that are common to a very small percentage of data.
The number of exams per patient, at each state of hepatitis does not suffer many changes, as can be seen in figure 6 . Furthermore, it is stable for patients with hepatitis C, with the exception of state 0 (no fibrosis). This can again be explained by the application of interferon therapy and respective evolution check.
MULTI-DIMENSIONAL DATA MINING
Data mining (DM) is defined as the non trivial extraction of implicit, previously unknown, and potentially useful information about data. In order to deal with multiple tables, data mining has to join somehow the different tables, creating the tuples to be mined. An option that allows the use of the existing single-table algorithms, is to join all the tables in one before mining (a step also known as propositionalization or denormalization). At a first glance, it may seem easy to join the tables into one, and then do the mining process on the joined result (Ng et al., 2002) . However, when multiple tables are joined, the resulting table will be much larger and sparser, with many repetitions of the same values, and the mining process more expensive and time consuming. Moreover, these repetitions of values may cause distortions in the calculations of the measures of interest and therefore hinder the discovery of really interesting patterns.
Multi-Relational Data Mining, or MRDM (Džeroski, 2003) is an area that aims for the discovery of frequent relations that involve multiple tables, in their original structure, i.e. without joining all the tables before mining.
In recent years, the most common mining techniques have been extended to the multi-relational context (Dehaspe and Raedt, 1997; Ng et al., 2002; Xu and Xie, 2006; Silva and Antunes, 2010; Silva and Antunes, 2012) . However, there are few capable of dealing with high number of records, and of taking into consideration all dimensions at the same time (Silva and Antunes, 2012) .
Frequent pattern mining is a sub-area of data mining that aims for enumerating all frequent patterns that conceptually represent relations among entities. A well-known example of a transactional pattern is a market-basket: the set of items that are bought together frequently by a customer. In this healthcare domain, an example of a transactional pattern is a set of frequent examinations performed and respective results. These frequent patterns can then be exploited in various ways: for further direct analysis, for creating association rules (Srikant, 1996) , expressing tendencies, and also, for example, for improving classification results and predictions.
Problem Definition
Following the example of the star schema in figure 2, dimensions (e.g. Patient) are composed of a primary key (e.g. PatientID) and a set of attributes describing the dimension (e.g. Sex and Age). Each dimension can be seen as a simple set of pairs (attribute, value), corresponding to the characteristics of the elements of that dimension. For example, patient 1 = {(Sex, M), (Age, 30) , ...}. In the context of data mining, an item is one of those pairs, and an itemset is just a set of pairs.
The central fact table (ExperimentationResults) contains one foreign key for each dimension, and a set of measurement fields. Conceptually, it comprises all business events (the actual occurrences). In this case, our fact table contains all performed examinations.
The support of an itemset is defined as the number of its occurrences in the database. In the case of a database modeled as a star schema, the number of occurrences of one item of some dimension (one pair attribute − value) depends on the number of occurrences of the respective transactions in the central table. A pattern P is a frequent itemset, i.e. an itemset whose support is greater or equal than a user defined minimum support threshold, and the problem of multi-dimensional frequent pattern mining over star schemas is to find all patterns in a star.
An association rule is an expression of the form X ⇒ Y , where X and Y are sets of items (Srikant, 1996) , and the intuitive meaning of such a rule is that database records which contain X tend to contain Y . They are built according to frequent patterns, and the support of a rule is the number of occurrences of X and Y , together, in the database. Another interesting measures used to evaluate association rules are the confidence and the lift. The confidence of a rule is the ratio between the support of the rule and the support of the antecedent, i.e. the probability of Y occur when X occurs. The lift measures the importance or unexpectedness of a rule. It is defined as the ratio between the confidence of the rule and its expected confidence (assuming X and Y are independent), and therefore the farther lift values are from 1, the more unexpected and important are the rules.
Related Work
There are many stand-alone algorithms to mine different types of patterns in traditional databases, but just some of these algorithms have been extended to the multi-relational case. In this work we focus on frequent pattern mining over star schemas. The first multi-relational methods have been developed by the Inductive Logic Programming community about ten years ago (Dehaspe and Raedt, 1997) , but they are usually not scalable with respect to the number of relations and attributes in the database and they need all data in the form of prolog tables. An aprioribased algorithm was introduced in (Crestana-Jensen and Soparkar, 2000) , which first generates frequent tuples in each single table, and then looks for frequent tuples whose items belong to different tables via a multi-dimensional count array; (Ng et al., 2002) proposed an algorithm that mines first each table separately, and then two tables at a time; (Xu and Xie, 2006) presented MultiClose, that first converts all dimension tables to a vertical data format, and then mines each of them locally, with a closed algorithm.
The algorithm StarFP-Growth (Silva and Antunes, 2010) is a pattern-growth method that is able to mine all dimensions without physically join them. The idea is simple and consists in finding first all frequent patterns in each dimension, based on the support given by the central table, and then finding all multi-dimensional patterns by using the central table again to know how and what local patterns cooccur. The algorithm uses an efficient tree structure to store the frequent itemsets, as well as an efficient pattern-growth strategy to generate and propagate the co-occurrences in a divide and conquer manner, and without the need for candidate generation.
In this work we decided to use StarFP-Growth, since it works directly on the whole star, and it is an efficient multi-dimensional algorithm.
RESULTS AND DISCUSSION
For the analysis of the hepatitis star schema, we decided to address two topics of interest, suggested for this dataset: (1) Discover the differences between patients with hepatitis B and C; and (2) Evaluate whether laboratory examinations can be used to estimate the stage of liver fibrosis. This second topic is of particular importance, since biopsies are invasive to patients, and therefore doctors try to avoid them.
By using the star in figure 2 we are able to relate the exams (and other dimensions) with the type of hepatitis, as well as with the fibrosis state. We can look for what examination results are common (frequent) along with hepatitis B or/and C, and see the differences (goal 1). Similarly, we can look for frequent exam results for each fibrosis state (goal 2), and then, for example, use those patterns to help classifying other patients with similar results.
Approach
At a first glance, the approach to follow may seem straightforward: we may apply StarFP-Growth to the hepatitis star, and choose all patterns that relate some examination result with hepatitis types and fibrosis states. However, as seen in section 3.2, only less than 1 fourth of all examinations have an active biopsy associated. In particular, 16% of examinations correspond to hepatitis C, and only 7% to hepatitis B.
First, this means that, to find the hepatitis type B as a frequent item (the same is valid for hepatitis C), we have to select a very low support, and in order to find some examination that is frequent along with hepatitis B, we have to set the support to even lower values. Furthermore, if we look to the frequency of examinations corresponding to each fibrosis state, we are talking about even lower supports. This leads to lots of uninteresting and possibly misleading patterns.
And second, if we are using all data to contribute for the support, highly frequent patterns (> 16% +7% = 23%) are frequent because they co-occur more in data with no biopsy information. And this means that they are not interesting because they cannot discriminate any type of hepatitis (at most, they can discriminate the non existence of hepatitis, if they are not frequent for any type of hepatitis).
In this sense, we decided to constrain the data, and apply StarFP-Growth with low supports: (1) B: to all examinations with hepatitis B; (2) C: to examinations with hepatitis C; and (3) None: to all exams with no biopsy data. This way, we found 3 sets of patterns: B, C and None. And then, we generated the association rules (with respective support, confidence and lift measures), based on the discovered patterns (also, 3 sets of rules, B, C and None).
Next, for the analysis, we categorized patterns and rules as discriminating or non-discriminating. A pattern is discriminating if it belongs to group B or/and C, but not to group None, i.e. if it is frequent for some type of hepatitis, and it is not frequent for those that are not diagnosed yet. Additionally, a pattern that belongs only to group None is also discriminating, since it may be a good to indicate that a patient do not have hepatitis. Patterns that belong to some group of hepatitis and at the same time to group None, are nondiscriminating, and thus not interesting. Discriminating patterns may be used to address goal 1, i.e. to understand the differences between hepatitis B and C.
Finally, we analyzed association rules that implicate some state of fibrosis, to understand if the state can be estimated by examination results (goal 2). Table 1 presents a subset of the frequent patterns found, with information about results and fibrosis. As expected, the supports of these patterns are very low (around 1%), in both groups. Patterns with more support correspond to patterns that are not discriminant However, by analyzing the differences between groups, we can find some possible interesting and discriminating examinations. For example, we find that ultra high (UH) values for the GPT test only appear in the hepatitis B test set (more than 1% of the time), but as the value lowers, the test stops being discriminant. Another examples are patterns 9 and 10, that may indicate that lower values on ALB and PLT tests are good markers for not having hepatitis (note that, in these data, not having information about a biopsy does not say that a person do not have hepatitis, but it may be an indicator for finding relations by which doctors think there is no need for a biopsy. Nevertheless, it needs further analysis). Pattern 8 is marked with an * because, as can be noted, it has 4% of support for hepatitis B, and only 1% in group None, and therefore it is considered non-discriminant. But, if we look to patterns 12 and 13, very low (VL) values for the CHE test may be an indicator of hepatitis B, meaning that pattern 8 occurrences in the None group may be outliers (or not yet diagnosed hepatitis B patients).
Interesting Patterns
The only discriminant patterns that relate exam results and the fibrosis state can only find a relation for fibrosis state 1 (patterns 13 to 15, in the table), because of the extremely low supports of other states of fibrosis. And in fact, high (H) values for GPT and GOT exams are not, by themselves, discriminant of hepatitis C (patterns 4 and 6). At most, they may be able to discriminate the fibrosis state in patients already diagnosed with hepatitis C. Table 2 presents a subset of the frequent association rules found of the form X ⇒ Fibrosis, with X any other item.
Association Rules
In order to address the second goal, we wanted to find all rules for which some examination result implies some fibrosis state. Rules 1 and 2 are examples of those rules. However, and although their confidence is around 50%, the lift is too close to 1, which means that these rules are not unexpected and are probably to tied to the data in question. Indeed, both antecedents were non discriminant (as seen in table 1), as well as these rules. All other rules of this form are equivalent, and furthermore, can only estimate the fibrosis state 1. This means that, using these data, no examination result, by itself, can predict the state of the fibrosis, in both type of hepatitis. Rules 3 and 4 are examples of rules with higher lift. They indicate that 20% of the patients that were born in de 60s (i.e. that were examined with 20 to 40 years old) had hepatitis in fibrosis state 0, and 62% of them in fibrosis state 1. Since these rules have higher lifts, this may denote a relation between the age of the patients with the state of the hepatitis.
Finally, rules 5 to 8 show that there are attributes that, although being discriminative, they are not good to predict the state of the fibrosis. In these examples, women born in the 30s can predict any state, from 1 to 4, with smaller confidences (with the exception of state 1, that is explained by the fact that there are more instances of this type) and bad lifts.
In (Pizzi et al., 2005) , the authors only generate and analyze the confidence of association rules of the form Examination Result → Fibrosis. However, besides the confidence of those rules be low (in most of the cases), neither the support or the lift of those rules was analyzed. As shown here, rules of that form with reasonable confidence (rules 1 and 2) have a lift too close to 1 (and a very low support), which means there are too few examples and these rules may not be significant.
These poor results mean that there is the need for further analysis of these data, in a different and more structured way. They also prove that there are some possible tendencies, but alone, examination results cannot predict fibrosis state of hepatitis patients.
In this work we presented a case study on the healthcare domain. Using the Hepatitis dataset, we showed how these data can be modeled and explored in a multi-dimensional model to promote decision support. We also discussed the use of a multi-dimensional data mining algorithm to mine this model.
Results over the Hepatitis dataset show that it is possible to mine these data and find interesting relations between dimensions. However, due to the nature and distributions of these data, interesting patterns found have very low support, and therefore, there is a need to further analysis. Our analysis over the discovered association rules concluded that the examination results present in the hepatitis dataset, explored as described, cannot predict the fibrosis state, mainly due to the very low supports.
As future work, and in order to surpass the difficulties of this dataset, other paths must be taken. One of the problems comes from the lack of data and their quality. The hepatitis dataset contains more than 30% of patients that did not perform any biopsy (undiagnosed), and more than 75% of examinations for which there is no information about an active biopsy. To have a better understanding about why these patients have not performed a biopsy requires domain knowledge, and may help partitioning the data and improve the results. In line with the above, this dataset contains a very low number of instances for each type and stage of hepatitis. There is the need for the integration and analysis of more data in this domain.
The use of different approaches may also result in better outcomes, such as infrequent pattern mining (Zhou and Yau, 2007) , for finding rare patterns; or sequential and temporal pattern mining, for the analysis of the evolution of the disease.
An important step should also be the discovery of structured patterns. Instead of considering one exam at a time, we can, for example, aggregate the data per pair (patient, biopsy), and using the same algorithm, find frequent examination results that are common to some type of hepatitis or that lead to some fibrosis state. These structured patterns can also be used as training data, in a further step, to improve classification results, and therefore improve the prediction of new hepatitis cases.
